AAV microdystrophin gene replacement therapy for Duchenne muscular dystrophy: progress and prospects
{{output}}
Duchenne muscular dystrophy (DMD) is caused by pathogenic sequence variants occurring in the DMD gene which lead to the loss of the dystrophin protein, a molecular 'shock absorber' that protects muscle from contraction-induced injury. The large size of the d... ...
